A Case of Anti‐TNFα Therapies Induced Lupus Panniculitis Successfully Improved With a JAK Inhibitor (Baricitinib)

ABSTRACT Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (1%–3% of CLE). There are two case reports to date in the literature of LEP potentially triggered by anti‐TNF‐α therapies. Clinically, it is characterised by tender, erythematous subcutaneous indurated...

Full description

Saved in:
Bibliographic Details
Main Authors: Cristina Grechin, Jane Doheny, Keith Pilson, Donough Howard, Muireann Roche
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:JEADV Clinical Practice
Subjects:
Online Access:https://doi.org/10.1002/jvc2.626
Tags: Add Tag
No Tags, Be the first to tag this record!